These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33343622)

  • 1. MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer.
    Escuin D; López-Vilaró L; Bell O; Mora J; Moral A; Pérez JI; Arqueros C; Ramón Y Cajal T; Lerma E; Barnadas A
    Front Genet; 2020; 11():562114. PubMed ID: 33343622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases.
    Escuin D; López-Vilaró L; Mora J; Bell O; Moral A; Pérez I; Arqueros C; García-Valdecasas B; Ramón Y Cajal T; Lerma E; Barnadas A
    Front Oncol; 2021; 11():627811. PubMed ID: 34513655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
    Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
    Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
    Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
    Sun D; Zhong J; Wei W; Chen X; Liu J; Hu Z
    J Gene Med; 2019 Apr; 21(4):e3075. PubMed ID: 30716792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs lnc-ANGPTL1-3:3 and lnc-GJA10-12:1 present as regulators of sentinel lymph node metastasis in breast cancer.
    Sun D; Zhong J; Wei W; Liu L; Liu J; Lin X
    Oncol Lett; 2020 Nov; 20(5):188. PubMed ID: 32952657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
    Dong LF; Xu SY; Long JP; Wan F; Chen YD
    J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma.
    Chua B; Ung O; Taylor R; Bilous M; Salisbury E; Boyages J
    Cancer; 2001 Oct; 92(7):1769-74. PubMed ID: 11745248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.
    Viale G; Maiorano E; Pruneri G; Mastropasqua MG; Valentini S; Galimberti V; Zurrida S; Maisonneuve P; Paganelli G; Mazzarol G
    Ann Surg; 2005 Feb; 241(2):319-25. PubMed ID: 15650643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
    Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
    Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
    Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
    Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
    Barron AU; Hoskin TL; Boughey JC
    Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
    Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
    Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.